查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1602727

解剖病理學測試市場：按組成部分、按應用分類 - 2025-2030 年全球預測

Anatomic Pathology Testing Market by Component (Consumables, Instruments, Services), Application (Disease Diagnosis, Drug Discovery & Development) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年解剖病理檢測市值為424.3億美元，預計2024年將達到450.3億美元，複合年成長率為6.22%，2030年將達到647.4億美元，預計將達到1000萬美元。

解剖病理學檢測是醫學診斷領域的重要組成部分，主要透過檢查組織樣本來診斷疾病、指南治療和進行研究。對解剖病理學測試的需求在於其無與倫比的能力，能夠提供對有效患者照護至關重要的準確診斷資訊，特別是在腫瘤學、感染疾病和器官移植評估方面。主要應用是切片檢查、外科病理學和細胞病理學，最終用戶是醫院、診斷實驗室和學術研究機構。該市場受到慢性病患病率上升、人口老化、醫療意識增強以及數位病理學和人工智慧整合等技術進步等因素的推動。個人化醫療需求的快速成長以及促進標靶治療的新型生物標記的開發正在創造關鍵的成長機會。擴大遠距病理學服務也有潛力，特別是在偏遠地區和專家很少的國家。然而，先進診斷技術的高成本、監管障礙和熟練病理學家短缺等挑戰可能會阻礙市場擴張。此外，資料隱私問題和對強大IT基礎設施的需求是進一步的限制因素。適合創新和研究的領域包括數位病理學的進步、人工智慧主導的診斷工具以及開發自動化病理測試設備以提高準確性和效率。科技公司和醫療保健提供者之間的合作可以創建簡化工作流程的整合平台。隨著解剖病理學領域的發展，專注於縮短週轉時間、提高診斷準確性和整合新技術對於尋求抓住成長機會的相關人員至關重要。該市場的特點是技術活力高、競爭激烈，要求相關人員採用顛覆性技術和策略夥伴關係來確保競爭。

主要市場統計
基準年[2023] 424.3億美元
預測年份 [2024] 450.3億美元
預測年份 [2030] 647.4億美元
複合年成長率（%） 6.22%

市場動態：揭示快速發展的解剖病理學測試市場的關鍵市場洞察

供需的動態交互作用正在改變解剖病理學測試市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 由於飲食習慣和生活方式的改變，抗癌藥物臨床試驗數量增加
    • 個人化醫療日益受到關注
    • 臨床中心對改善診斷程序的需求迅速增加
  • 市場限制因素
    • 缺乏熟練的專業人員
  • 市場機會
    • 解剖病理學測試的進展提供有針對性的覆蓋
    • 增強對研究惡性和腫瘤發展的生物標記特異性病理測試和程序的信心
  • 市場問題
    • 政府嚴格的規章制度

波特五力：駕馭解剖病理學測試市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對解剖病理學檢測市場的影響

外部宏觀環境因素在塑造解剖病理學測試市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解解剖病理學檢測市場的競爭格局

解剖病理學測試市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣：解剖病理學測試市場供應商的績效評估

FPNV 定位矩陣是評估解剖病理學測試市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製解剖病理學測試市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對解剖病理學測試市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 由於飲食習慣和生活方式的改變，與癌症治療相關的臨床試驗正在增加。
      • 個人化醫療日益受到關注
      • 臨床中心對改善診斷程序的需求迅速增加
    • 抑制因素
      • 缺乏熟練的專業人員
    • 機會
      • 解剖病理學測試的進展提供有針對性的覆蓋
      • 越來越依賴使用生物標記的病理測試和治療來研究惡性和腫瘤形成
    • 任務
      • 政府嚴格的規章制度
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章解剖病理學測試市場：按組成部分

  • 介紹
  • 消耗品
  • 裝置
  • 服務

第7章解剖病理學測試市場：依應用分類

  • 介紹
  • 疾病診斷
  • 藥物發現與開發

第8章 北美、南美洲解剖病理檢測市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太解剖病理檢測市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲/中東/非洲解剖病理檢測市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • Danaher Corporation
  • Diapath SpA
  • Digipath, Inc.
  • Enzo Biochem, Inc.
  • Epic Sciences
  • Epredia
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Quest Diagnostics Incorporated
  • Sakura Finetek USA, Inc.
Product Code: MRR-436901066173

The Anatomic Pathology Testing Market was valued at USD 42.43 billion in 2023, expected to reach USD 45.03 billion in 2024, and is projected to grow at a CAGR of 6.22%, to USD 64.74 billion by 2030.

Anatomic pathology testing is a vital component of the medical diagnostics field, focusing on the examination of tissue samples to diagnose diseases, guide treatment, and conduct research. The necessity of anatomic pathology testing lies in its unparalleled ability to deliver precise diagnostic information essential for effective patient care, especially in oncology, infectious diseases, and organ transplant evaluations. The primary applications involve biopsy, surgical pathology, and cytopathology, with end-users comprising hospitals, diagnostic labs, academic and research institutes. The market is driven by factors like the rising prevalence of chronic diseases, the aging population, increasing healthcare awareness, and technological advancements such as digital pathology and AI integration. Key growth opportunities are emerging due to the surging demand for personalized medicine and the development of novel biomarkers that facilitate targeted therapy. There is also a potential in expanding telepathology services, especially in remote areas or countries with fewer specialized professionals. However, challenges such as the high cost of advanced diagnostic technologies, regulatory hurdles, and a shortage of skilled pathologists may inhibit market expansion. Furthermore, data privacy concerns and the need for robust IT infrastructure pose additional constraints. The best areas for innovation and research include advancements in digital pathology, AI-driven diagnostic tools, and the development of automated pathology equipment to improve accuracy and efficiency. Collaborations between technology firms and healthcare providers can enable the creation of integrated platforms that streamline workflow processes. As the anatomic pathology landscape evolves, focus on improving turnaround times, enhancing diagnostic accuracy, and integrating new technologies are crucial for stakeholders aiming to seize growing opportunities. The market is characterized by high technological dynamism and competitive intensity, urging stakeholders to adopt disruptive technologies and strategic partnerships to secure a competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 42.43 billion
Estimated Year [2024] USD 45.03 billion
Forecast Year [2030] USD 64.74 billion
CAGR (%) 6.22%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Anatomic Pathology Testing Market

The Anatomic Pathology Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in the number of clinical trials pertaining to cancer drugs due to changes in food habits and lifestyle
    • Increasing focus on personalized medicine
    • Surge in demand to improve the diagnostic procedure in clinical centers
  • Market Restraints
    • Unavailability of skilled professionals
  • Market Opportunities
    • Advances in anatomic pathology testing providing targeted coverage
    • Growth in reliance on biomarkers-based pathology tests and procedures for exploring malignancy and tumorigenesis
  • Market Challenges
    • Strigent rules and regulations by the government

Porter's Five Forces: A Strategic Tool for Navigating the Anatomic Pathology Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Anatomic Pathology Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Anatomic Pathology Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Anatomic Pathology Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Anatomic Pathology Testing Market

A detailed market share analysis in the Anatomic Pathology Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Anatomic Pathology Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Anatomic Pathology Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Anatomic Pathology Testing Market

A strategic analysis of the Anatomic Pathology Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Anatomic Pathology Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies Inc., Becton, Dickinson and Company, Cardinal Health, Inc., Danaher Corporation, Diapath S.p.A., Digipath, Inc., Enzo Biochem, Inc., Epic Sciences, Epredia, F. Hoffmann-La Roche AG, Hologic, Inc., Laboratory Corporation of America Holdings, Merck KGaA, Quest Diagnostics Incorporated, and Sakura Finetek USA, Inc..

Market Segmentation & Coverage

This research report categorizes the Anatomic Pathology Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Component, market is studied across Consumables, Instruments, and Services.
  • Based on Application, market is studied across Disease Diagnosis and Drug Discovery & Development.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in the number of clinical trials pertaining to cancer drugs due to changes in food habits and lifestyle
      • 5.1.1.2. Increasing focus on personalized medicine
      • 5.1.1.3. Surge in demand to improve the diagnostic procedure in clinical centers
    • 5.1.2. Restraints
      • 5.1.2.1. Unavailability of skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Advances in anatomic pathology testing providing targeted coverage
      • 5.1.3.2. Growth in reliance on biomarkers-based pathology tests and procedures for exploring malignancy and tumorigenesis
    • 5.1.4. Challenges
      • 5.1.4.1. Strigent rules and regulations by the government
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Anatomic Pathology Testing Market, by Component

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments
  • 6.4. Services

7. Anatomic Pathology Testing Market, by Application

  • 7.1. Introduction
  • 7.2. Disease Diagnosis
  • 7.3. Drug Discovery & Development

8. Americas Anatomic Pathology Testing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Anatomic Pathology Testing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Anatomic Pathology Testing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies Inc.
  • 3. Becton, Dickinson and Company
  • 4. Cardinal Health, Inc.
  • 5. Danaher Corporation
  • 6. Diapath S.p.A.
  • 7. Digipath, Inc.
  • 8. Enzo Biochem, Inc.
  • 9. Epic Sciences
  • 10. Epredia
  • 11. F. Hoffmann-La Roche AG
  • 12. Hologic, Inc.
  • 13. Laboratory Corporation of America Holdings
  • 14. Merck KGaA
  • 15. Quest Diagnostics Incorporated
  • 16. Sakura Finetek USA, Inc.

LIST OF FIGURES

  • FIGURE 1. ANATOMIC PATHOLOGY TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ANATOMIC PATHOLOGY TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ANATOMIC PATHOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ANATOMIC PATHOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANATOMIC PATHOLOGY TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANATOMIC PATHOLOGY TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ANATOMIC PATHOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. ANATOMIC PATHOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2023